Criteria for Changing Treatment in Narcolepsy: Part 1

EP: 1.Classic Features of Narcolepsy

EP: 2.The Frequency of Occurrence of Narcolepsy Symptoms

EP: 3.Contributing Factors to Narcolepsy

EP: 4.Quality of Life of Patients With Narcolepsy

EP: 5.Treatment Selection in Patients With Narcolepsy

EP: 6.Treatment Classes for Narcolepsy

EP: 7.Safety Data on Emerging Treatment of Narcolepsy

EP: 8.Use of Narcolepsy Treatments in Different Patients: Part 1

EP: 9.Use of Narcolepsy Treatments in Different Patients: Part 2

EP: 10.Treating Narcolepsy in Pregnancy

EP: 11.Abuse and Dependency Potential With Newer Narcolepsy Treatment

EP: 12.Use and Uptake of Newer Narcolepsy Treatments in Clinical Practice

Now Viewing

EP: 13.Criteria for Changing Treatment in Narcolepsy: Part 1

EP: 14.Criteria for Changing Treatment in Narcolepsy: Part 2

EP: 15.Drug Holidays in Narcolepsy

EP: 16.Ongoing Studies and New Treatments for Narcolepsy

EP: 17.Final Advice for Clinicians Treating Narcolepsy

This is a video synopsis/summary of a panel discussion involving Michael Thorpy, MD; Karl Doghramji, MD, FAASM, DFAPA; Clete Kushida, MD, PhD; and Richard K Bogan, MD.

Experts discusses considerations for changing medications in narcolepsy patients due to side effects or declining effectiveness. The decision-making process for switching medications is highlighted, with a focus on assessing symptoms, particularly excessive daytime sleepiness, at each encounter with the patient. Objective testing, such as overnight studies with the Multiple Sleep Latency Test (MSLT), may be necessary, especially if subjective history is unreliable. Special populations, such as commercial drivers, may require additional tests like Maintenance of Wakefulness Test (MWT) to ensure safety. Patient-reported outcome measures, including sleep-related questionnaires and scales for anxiety and depression, are used to monitor treatment response. However, questionnaire fatigue is acknowledged, and careful consideration is given to the frequency and variety of assessments to minimize patient burden while still ensuring comprehensive monitoring of symptoms and treatment effectiveness.

Video synopsis is AI-generated and reviewed by NeurologyLive editorial staff.